Case Reports
Vol. 12 (2024)
https://doi.org/10.4081/cdr.12.12822

A confusing lesion: pulmonary inflammatory myofibroblast tumour

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 18 July 2024
Accepted: 21 August 2024
Published: 23 August 2024
712
Views
193
Downloads
Pulmonary lesion, malignancy, Inflammatory Myofibroblastic Tumour, Computed Tomography

Authors

Sümeyye Sekmen
drsumeyyesekmen@gmail.com
https://orcid.org/0000-0003-1609-6775
Department of Radiology, Recep Tayyip Erdogan University, Rize, Türkiye.
Nur Hürsoy
Department of Radiology, Recep Tayyip Erdogan University, Rize, Türkiye.
Kemal Panç
https://orcid.org/0000-0002-3951-7344
Department of Radiology, Karakocan State Hospital, Elazığ, Türkiye.

Inflammatory Myofibroblastic Tumours (IMT), also known as plasma cell granuloma, is a mesenchymal neoplasm that can be observed in almost every tissue. IMT is very rare with an incidence of approximately 0.04-1% of all pulmonary masses in adults. In children, it is the most common primary mass of the lung. Imaging findings of IMT are variable and nonspecific, probably due to fibrosis and cellular infiltration. They can cause difficulties in the diagnostic process due to differences in imaging characteristics.

Downloads

Download data is not yet available.
Sagar AS, Jimenez CA, Shannon VR. Clinical and histopathologic correlates and management strategies for Inflammatory Myofibroblastic Tumor of the lung. A case series and review of the literature. Med Oncol 2018;35:102. DOI: https://doi.org/10.1007/s12032-018-1161-0
Chen CK, Jan CI, Tsai JS, et al. Inflammatory myofibroblastic tumor of the lung - a case report. J Cardiothorac Surg. 2010;5:55. DOI: https://doi.org/10.1186/1749-8090-5-55
Pavithran K, Manoj P, Vidhyadharan G, Shanmughasundaram P. Inflammatory Myofibroblastic Tumor of the lung: unusual imaging findings. World J Nucl Med 2013;12:126-8. DOI: https://doi.org/10.4103/1450-1147.136739
García IV, Gutierrez AS, Guzmán SB, Viveros BA. Inflammatory myofibroblastic tumor in pediatric patients: challenges in diagnosis, multidisciplinary management, and surgical strategies. Egypt Pediatric Association Gaz 2024;72:26. DOI: https://doi.org/10.1186/s43054-024-00269-z
Poyraz N, Yazar ME, Kılınç F, et al. Akciğerin inflamatuvar miyofibroblastik tümörü: histopatoloji ve görüntüleme bulguları. Tuberk Toraks 2020;68:321-7. DOI: https://doi.org/10.5578/tt.69793
Karapolat S, Seyis KN, Ersoz S, et al. Lung image: Inflammatory Myofibroblastic Tumor. Lung 2017;195:387-8. DOI: https://doi.org/10.1007/s00408-017-0002-9
Tsuchiya T, Tanaka M. Pulmonary Inflammatory Myofibroblastic Tumor: a case report. Asian Cardiovascular and Thoracic Annals. 2018;26:317-9. DOI: https://doi.org/10.1177/0218492318770845
Wang QA, Chen HW, Wu RC, Wu CE. Update of diagnosis and targeted therapy for ALK+ Inflammation Myofibroblastic Tumor. Curr Treat Options Oncol. 2023;24:1683-702. DOI: https://doi.org/10.1007/s11864-023-01144-6

How to Cite



A confusing lesion: pulmonary inflammatory myofibroblast tumour. (2024). Chest Disease Reports, 12(1). https://doi.org/10.4081/cdr.12.12822
Copyright (c) 2024 the Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.